2462 studies found for:    "Hepatitis"
Show Display Options
RSS Create an RSS feed from your search for:
"Hepatitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
Conditions: Liver Diseases;   Hepatitis, Chronic;   Hepatitis, Viral, Human;   Hepatitis;   Virus Diseases;   Digestive System Diseases;   Hepatitis B, Chronic;   Hepatitis B;   DNA Virus Infections
Intervention:
2 Completed
Has Results
Lamivudine and Adefovir to Treat Chronic Hepatitis B
Conditions: HBV (Hepatitis B Virus);   Hepatitis B;   Hepatitis
Interventions: Drug: Lamivudine and adefovir;   Drug: Adefovir alone
3 Recruiting Non-invasive Biomarkers of Fibrosis in Pediatric Viral Hepatitis
Conditions: Viral Hepatitis;   Liver Fibrosis;   Liver Disease;   Hepatitis B;   Hepatitis C
Intervention:
4 Unknown  Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Conditions: Hepatitis C;   Hepatitis B;   Autoimmune Hepatitis;   Liver Cirrhosis, Biliary;   Cholangitis, Sclerosing
Intervention:
5 Terminated Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis
Conditions: Acute Hepatitis A;   Acute Hepatitis B;   Acute Hepatitis C;   Acute Hepatitis E;   Acute EBV Hepatitis;   Acute CMV Hepatitis
Interventions: Dietary Supplement: Silymarin;   Other: Lactose monohydrate
6 Enrolling by invitation A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1
Interventions: Drug: ABT-450/r;   Drug: ABT-267;   Drug: pegylated interferon alpha-2a (pegIFN);   Drug: Ribavirin (RBV)
7 Recruiting New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
Conditions: Cirrhosis;   Chronic Hepatitis C;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Asunaprevir and Daclatsvir;   Drug: Asunaprevir, daclatsvir, peginterferon, ribavirin
8 Completed Lamivudine for Chronic Hepatitis B
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D;   Glomerulonephritis;   Polyarteritis Nodosa
Intervention: Drug: Lamivudine
9 Completed Investigation of Hepatitis B and Hepatitis C in Taiwan
Conditions: Hepatitis B;   Hepatitis C
Intervention: Biological: blood sampling and abdominal sonography
10 Completed Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients
Conditions: Hepatitis;   Hepatitis B;   Lymphoma;   Hematologic Diseases
Intervention:
11 Completed Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C
Conditions: Hepatitis C;   Chronic Hepatitis C
Interventions: Other: Mailer;   Other: In-person recruitment;   Other: EHR Alert
12 Terminated Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults
Conditions: Hepatitis C, Chronic;   Hepatitis C
Intervention: Drug: GSK625433/placebo
13 Withdrawn Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients
Conditions: Hepatitis B;   Human Immunodeficiency Virus;   Hepatitis C, Chronic
Interventions: Drug: maraviroc;   Drug: etravirine
14 Completed Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: TWINRIX™;   Biological: Engerix™-B;   Biological: HAVRIX™;   Biological: HB VAX PRO™;   Biological: Vaqta™
15 Active, not recruiting A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)
Conditions: Chronic Hepatitis C;   Hepatitis C Virus;   Compensated Cirrhosis
Interventions: Drug: ABT-493;   Drug: ABT-530;   Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
16 Completed
Has Results
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule
Conditions: Hepatitis B;   Hepatitis A
Intervention: Biological: Twinrix™ adult
17 Recruiting Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C
Conditions: RNA Virus Infections;   Flaviviridae Infections;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Vitamin D;   Drug: Vitamin B 12
18 Recruiting A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 or Genotype 3 Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus
Interventions: Drug: ABT-493;   Drug: ABT-530;   Drug: Ribavirin (RBV)
19 Not yet recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 With Ribavirin in Adults With Genotype 1 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
Conditions: Chronic Hepatitis C;   Decompensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ABT-450/ritonavir/ABT-267;   Drug: ABT-333;   Drug: Ribavirin
20 Recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
Conditions: Chronic Hepatitis C Infection;   Compensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years